NewsRx

Search our medical news database

Dementia

Abiant, Inc. Announces License Agreement with New York University School of Medicine

Published in Telemedicine Business Week, November 28th, 2007

Abiant, Inc., an Illinois based company specializing in advanced bio-imaging to accelerate and improve drug development and disease diagnosis, announces an exclusive technology license agreement with the New York University School of Medicine. The technology involves breakthrough image analysis methods developed by leading researchers at New York University School of Medicine to reliably detect changes in critical brain regions that are predictive of the onset of Alzheimer's Disease. It also has application in oncology and other disease areas.

Dr. Mony de Leon, Director of New York University School of Medicine's Center for Brain Health, said "We believe that these...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Telemedicine Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook